His primary scientific interests are in Microbiology, Burkholderia cepacia complex, Burkholderia, Cystic fibrosis and Pseudomonas aeruginosa. John R. W. Govan is studying Antibiotic resistance, which is a component of Microbiology. His Burkholderia cepacia complex research focuses on Burkholderia cenocepacia and how it relates to Pathogen.
His studies in Burkholderia integrate themes in fields like Genome and Microbial ecology. His Cystic fibrosis research is multidisciplinary, incorporating perspectives in Surgery and Immunology. The Immunology study combines topics in areas such as Gastroenterology and Internal medicine, Lung.
His primary areas of study are Microbiology, Cystic fibrosis, Pseudomonas aeruginosa, Immunology and Burkholderia cepacia complex. His studies in Microbiology integrate themes in fields like Genomovar, Virulence and Burkholderia, Bacteria. John R. W. Govan has researched Cystic fibrosis in several fields, including Antibiotics, Infection control and Pseudomonas.
As a part of the same scientific study, he usually deals with the Pseudomonas aeruginosa, concentrating on Antibiotic resistance and frequently concerns with Tobramycin. The various areas that John R. W. Govan examines in his Immunology study include Respiratory disease, Internal medicine, Lung, Bronchiectasis and Gastroenterology. His Burkholderia cepacia complex study combines topics in areas such as Bacteriophage and Burkholderia cenocepacia.
John R. W. Govan mainly focuses on Cystic fibrosis, Immunology, Microbiology, Pseudomonas aeruginosa and Bronchiectasis. His work deals with themes such as Antibiotics, Mannan-binding lectin, MBL deficiency and Negative regulator, which intersect with Cystic fibrosis. His Immunology study incorporates themes from Fibrosis, Pathology and Lung.
His research integrates issues of Acute appendicitis, Molecular typing and Pseudomonas in his study of Microbiology. His Pseudomonas aeruginosa research includes themes of Gene, Whole genome sequencing, Mutation and Virology. His Bronchiectasis study integrates concerns from other disciplines, such as Gastroenterology, Exacerbation, Haemophilus influenzae and Neutrophil elastase.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Bronchiectasis, Immunology and Cystic fibrosis. His work on Severity of illness, Vitamin, Case-control study and Incidence as part of general Internal medicine research is frequently linked to vitamin D deficiency, thereby connecting diverse disciplines of science. His Bronchiectasis study deals with Exacerbation intersecting with Intensive care, Randomized controlled trial, Antibacterial agent, Anesthesia and Lung.
His Cystic fibrosis study typically links adjacent topics like Surgery. His study looks at the intersection of Surgery and topics like Respiratory infection with Pseudomonas aeruginosa. John R. W. Govan usually deals with Pseudomonas aeruginosa and limits it to topics linked to In vivo and Microbiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
J. R.W. Govan;V. Deretic.
Microbiological Research (1996)
Taxonomy and Identification of the Burkholderia cepacia Complex
Tom Coenye;Peter Vandamme;John R. W. Govan;John J. LiPuma.
Journal of Clinical Microbiology (2001)
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
K. Cheng;R. L. Smyth;J. R. W. Govan;C. Doherty.
The Lancet (1996)
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
James D. Chalmers;Maeve P. Smith;Brian J. McHugh;Cathy Doherty.
American Journal of Respiratory and Critical Care Medicine (2012)
Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex
Eshwar Mahenthiralingam;Tom Coenye;Jacqueline W. Chung;David P. Speert.
Journal of Clinical Microbiology (2000)
The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients
Matthew T. G. Holden;Helena M. B. Seth-Smith;Lisa C. Crossman;Mohammed Sebaihia.
Journal of Bacteriology (2009)
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.
Tom Coenye;Enevold Falsen;Marc Vancanneyt;Bart Hoste.
International Journal of Systematic and Evolutionary Microbiology (1999)
A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
Maeve P. Murray;John R. W. Govan;Catherine J. Doherty;A. John Simpson.
American Journal of Respiratory and Critical Care Medicine (2011)
Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic
Andrew M. Jones;John R W Govan;Catherine J. Doherty;Mary E. Dodd.
The Lancet (2001)
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
A M Jones;M E Dodd;J R W Govan;V Barcus.
Thorax (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Ghent University
University of Liverpool
Ghent University
University of Edinburgh
Cardiff University
University of Edinburgh
University of Manchester
University of Michigan–Ann Arbor
University of Edinburgh
University of British Columbia
University of South Florida
Sandia National Laboratories
KU Leuven
La Trobe University
University of Gothenburg
Chinese Academy of Sciences
Maastricht University
Fred Hutchinson Cancer Research Center
Technical University of Munich
University of Florida
Oregon State University
American Museum of Natural History
University of Fribourg
University of Florence
University of Toronto
New York University